全文获取类型
收费全文 | 6841篇 |
免费 | 491篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 194篇 |
妇产科学 | 83篇 |
基础医学 | 878篇 |
口腔科学 | 118篇 |
临床医学 | 553篇 |
内科学 | 1697篇 |
皮肤病学 | 236篇 |
神经病学 | 722篇 |
特种医学 | 237篇 |
外科学 | 983篇 |
综合类 | 34篇 |
预防医学 | 238篇 |
眼科学 | 143篇 |
药学 | 519篇 |
中国医学 | 15篇 |
肿瘤学 | 669篇 |
出版年
2024年 | 15篇 |
2023年 | 163篇 |
2022年 | 300篇 |
2021年 | 534篇 |
2020年 | 227篇 |
2019年 | 285篇 |
2018年 | 319篇 |
2017年 | 235篇 |
2016年 | 249篇 |
2015年 | 258篇 |
2014年 | 290篇 |
2013年 | 329篇 |
2012年 | 516篇 |
2011年 | 514篇 |
2010年 | 276篇 |
2009年 | 208篇 |
2008年 | 351篇 |
2007年 | 305篇 |
2006年 | 318篇 |
2005年 | 293篇 |
2004年 | 278篇 |
2003年 | 224篇 |
2002年 | 187篇 |
2001年 | 88篇 |
2000年 | 67篇 |
1999年 | 52篇 |
1998年 | 38篇 |
1997年 | 33篇 |
1996年 | 19篇 |
1995年 | 17篇 |
1994年 | 20篇 |
1993年 | 21篇 |
1992年 | 40篇 |
1991年 | 23篇 |
1990年 | 38篇 |
1989年 | 22篇 |
1988年 | 19篇 |
1987年 | 22篇 |
1986年 | 15篇 |
1985年 | 12篇 |
1984年 | 17篇 |
1983年 | 8篇 |
1979年 | 8篇 |
1977年 | 12篇 |
1976年 | 8篇 |
1975年 | 10篇 |
1974年 | 9篇 |
1971年 | 8篇 |
1969年 | 7篇 |
1967年 | 7篇 |
排序方式: 共有7365条查询结果,搜索用时 15 毫秒
91.
92.
The effect of skill mix in non‐nursing assistants on work engagements among home visiting nurses in Japan
下载免费PDF全文
![点击此处可从《Journal of nursing management》网站下载免费的PDF全文](/ch/ext_images/free.gif)
93.
94.
95.
Naoko Uetsu Yuki Nomura Yoshie Matsuyama Hiroyuki Okamoto 《The Journal of dermatology》2020,47(4):369-377
Solar urticaria has unique spectra, such as inhibition and augmentation. The clinical significance of these spectra, especially augmentation, is not well understood. Reported cases of solar urticaria with augmentation spectra are extremely rare in the published English-language work. The purposes of this study were to evaluate the clinical features of solar urticaria with augmentation spectra and to elucidate the mechanisms and clinical importance of the spectra. We experienced 11 cases (five females, six males; mean age, 40.1 years; range, 1–74) of solar urticaria with augmentation spectra from April 2007 to July 2019. Augmentation spectra were UV-B in three cases, UV-A in two, visible light in four, UV-A and UV-B in one, and UV-A and visible light in one. Augmentation spectra were observed before action spectra in four cases, after in six, and before and after in one. Injection of sera irradiated with action spectra and augmentation spectra in vitro induced stronger immediate reactions than those of only action spectrum-irradiated sera in four of five cases. The results of injection tests suggested that augmentation spectra enhance the production of urticaria-forming factor. Clinically, we observed severe urticarial reactions in four cases, including anaphylaxis in three and moderate urticarial reactions in three. These results suggest that augmentation spectra are not as rare as previously thought and that they are associated with the severity of solar urticaria. Therefore, phototesting for both augmentation and action spectra should be performed to provide appropriate guidance for patients with solar urticaria. 相似文献
96.
Risa Konishi Ryota Tanaka Sae Inoue Yuki Ichimura Toshifumi Nomura Naoko Okiyama 《The Journal of dermatology》2022,49(1):118-123
Dermatomyositis, an idiopathic inflammatory myopathy, is characterized by cutaneous itchy manifestations, which are frequently refractory and recurrent even after intensive immunosuppressive treatments. To evaluate the effectiveness and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in treating skin-dominant dermatomyositis in which myositis and interstitial lung disease are absent or in remission, we performed this prospective, single-arm, interventional study. A total of five Japanese patients (one male and four females, median [range] age, 64 [37–71] years) with refractory dermatomyositis-associated cutaneous manifestations were recruited and treated with a 12-week course of oral apremilast. Among five enrolled patients, three experienced diarrhea with full-dose apremilast (30 mg twice daily), two of whom withdrew from the study and recovered quickly afterwards. A total of three evaluable female patients (median [range] age, 65 [64–71] years) received apremilast treatment for 12 weeks. A 39.4% reduction from baseline Cutaneous Dermatomyositis Disease Area and Severity Index total activity score, but not the damage score, at week 12 was observed in all three patients. Visual analog scale of itching, and quality of life by Dermatology Life Quality Index were slightly improved in one and two apremilast-treated patients, respectively. As apremilast was effective, with expected and recoverable digestive adverse events (diarrhea), in patients with refractory and recurrent dermatomyositis-associated cutaneous manifestations in this first phase Ib study, it can be suggested as a possible treatment when aggressive immunosuppressive therapies with high-dose systemic corticosteroid and/or immunosuppressive agents for other manifestations, myositis, and interstitial lung disease, are not required. 相似文献
97.
Smartphones have become essential devices in modern society. The coverage rate of smartphones in 2017 in Japan was 75% according to the Ministry of Internal Affairs and Communications. The iPhone is one of the most well-known smartphone brands. According to the manufacturer of iPhones (Apple), more than 200 million iPhones had been sold worldwide by 2017. These devices are often charged at night-time, especially while being used in bed. There are only three reports of smartphone charger-induced skin damage. We present two new cases of skin ulcers induced by an iPhone charger. The iPhone’s “lightning cable” has electrodes outside, and we found that this can present a higher risk of causing a skin injury compared with other types of phone chargers. We also investigated the mechanism of the skin ulcers caused by the iPhone charger. The results indicated that these ulcers were chemical burns rather than an electrical injury or heat-induced burn. 相似文献
98.
99.
100.